vs
GRID DYNAMICS HOLDINGS, INC.（GDYN）与MESA LABORATORIES INC（MLAB）财务数据对比。点击上方公司名可切换其他公司
GRID DYNAMICS HOLDINGS, INC.的季度营收约是MESA LABORATORIES INC的1.6倍（$104.1M vs $65.1M），MESA LABORATORIES INC净利率更高（5.6% vs -1.4%，领先7.0%），GRID DYNAMICS HOLDINGS, INC.同比增速更快（3.7% vs 3.6%），过去两年GRID DYNAMICS HOLDINGS, INC.的营收复合增速更高（12.0% vs 5.1%）
Escape Dynamics Inc.是一家总部位于科罗拉多州的科技企业，活跃于2010年至2015年，核心业务方向是研发可单级入轨、依靠电磁驱动的可重复使用航天飞机，并推动该项目实现商业化落地。
梅萨实验室有限公司开发、生产和销售专业质控、校准及监测仪器与配套服务，核心业务覆盖医疗健康、制药、食品饮料、工业卫生及环境检测领域，为全球客户满足合规及运营安全需求提供支持。
GDYN vs MLAB — 直观对比
营收规模更大
GDYN
是对方的1.6倍
$65.1M
营收增速更快
GDYN
高出0.0%
3.6%
净利率更高
MLAB
高出7.0%
-1.4%
两年增速更快
GDYN
近两年复合增速
5.1%
损益表 — Q1 FY2026 vs Q3 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $104.1M | $65.1M |
| 净利润 | $-1.5M | $3.6M |
| 毛利率 | 34.8% | 64.2% |
| 营业利润率 | 61.7% | 12.2% |
| 净利率 | -1.4% | 5.6% |
| 营收同比 | 3.7% | 3.6% |
| 净利润同比 | -150.6% | 316.6% |
| 每股收益（稀释后） | $-0.02 | $0.65 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收GDYNMLAB
| Q1 26 | $104.1M | — | ||
| Q4 25 | $106.2M | $65.1M | ||
| Q3 25 | $104.2M | $60.7M | ||
| Q2 25 | $101.1M | $59.5M | ||
| Q1 25 | $100.4M | $62.1M | ||
| Q4 24 | $100.3M | $62.8M | ||
| Q3 24 | $87.4M | $57.8M | ||
| Q2 24 | $83.0M | $58.2M |
净利润GDYNMLAB
| Q1 26 | $-1.5M | — | ||
| Q4 25 | $306.0K | $3.6M | ||
| Q3 25 | $1.2M | $2.5M | ||
| Q2 25 | $5.3M | $4.7M | ||
| Q1 25 | $2.9M | $-7.1M | ||
| Q4 24 | $4.5M | $-1.7M | ||
| Q3 24 | $4.3M | $3.4M | ||
| Q2 24 | $-817.0K | $3.4M |
毛利率GDYNMLAB
| Q1 26 | 34.8% | — | ||
| Q4 25 | 34.0% | 64.2% | ||
| Q3 25 | 33.3% | 61.5% | ||
| Q2 25 | 34.1% | 62.0% | ||
| Q1 25 | 36.8% | 61.8% | ||
| Q4 24 | 36.9% | 63.3% | ||
| Q3 24 | 37.4% | 61.3% | ||
| Q2 24 | 35.6% | 64.0% |
营业利润率GDYNMLAB
| Q1 26 | 61.7% | — | ||
| Q4 25 | 0.5% | 12.2% | ||
| Q3 25 | -0.2% | 7.8% | ||
| Q2 25 | -0.1% | 5.1% | ||
| Q1 25 | -2.0% | 2.4% | ||
| Q4 24 | 1.3% | 9.2% | ||
| Q3 24 | 2.4% | 6.1% | ||
| Q2 24 | 0.0% | 9.6% |
净利率GDYNMLAB
| Q1 26 | -1.4% | — | ||
| Q4 25 | 0.3% | 5.6% | ||
| Q3 25 | 1.1% | 4.1% | ||
| Q2 25 | 5.2% | 8.0% | ||
| Q1 25 | 2.9% | -11.4% | ||
| Q4 24 | 4.5% | -2.7% | ||
| Q3 24 | 4.9% | 5.9% | ||
| Q2 24 | -1.0% | 5.8% |
每股收益（稀释后）GDYNMLAB
| Q1 26 | $-0.02 | — | ||
| Q4 25 | $0.01 | $0.65 | ||
| Q3 25 | $0.01 | $0.45 | ||
| Q2 25 | $0.06 | $0.85 | ||
| Q1 25 | $0.03 | $-1.30 | ||
| Q4 24 | $0.06 | $-0.31 | ||
| Q3 24 | $0.05 | $0.63 | ||
| Q2 24 | $-0.01 | $0.62 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $327.5M | $29.0M |
| 总债务越低越好 | — | $68.4M |
| 股东权益账面价值 | $530.1M | $186.7M |
| 总资产 | $605.0M | $434.8M |
| 负债/权益比越低杠杆越低 | — | 0.37× |
8季度趋势，按日历期对齐
现金及短期投资GDYNMLAB
| Q1 26 | $327.5M | — | ||
| Q4 25 | $342.1M | $29.0M | ||
| Q3 25 | $338.6M | $20.4M | ||
| Q2 25 | $336.8M | $21.3M | ||
| Q1 25 | $325.5M | $27.3M | ||
| Q4 24 | $334.7M | $27.3M | ||
| Q3 24 | $231.3M | $24.3M | ||
| Q2 24 | $256.0M | $28.5M |
总债务GDYNMLAB
| Q1 26 | — | — | ||
| Q4 25 | — | $68.4M | ||
| Q3 25 | — | $69.4M | ||
| Q2 25 | — | $70.3M | ||
| Q1 25 | — | $71.3M | ||
| Q4 24 | — | $72.2M | ||
| Q3 24 | — | $73.1M | ||
| Q2 24 | — | $74.1M |
股东权益GDYNMLAB
| Q1 26 | $530.1M | — | ||
| Q4 25 | $542.1M | $186.7M | ||
| Q3 25 | $537.7M | $178.5M | ||
| Q2 25 | $532.2M | $172.5M | ||
| Q1 25 | $517.4M | $159.8M | ||
| Q4 24 | $517.8M | $155.2M | ||
| Q3 24 | $400.2M | $161.5M | ||
| Q2 24 | $388.4M | $150.7M |
总资产GDYNMLAB
| Q1 26 | $605.0M | — | ||
| Q4 25 | $612.9M | $434.8M | ||
| Q3 25 | $613.2M | $430.4M | ||
| Q2 25 | $608.9M | $435.7M | ||
| Q1 25 | $590.9M | $433.3M | ||
| Q4 24 | $592.2M | $433.3M | ||
| Q3 24 | $477.3M | $454.1M | ||
| Q2 24 | $443.6M | $440.4M |
负债/权益比GDYNMLAB
| Q1 26 | — | — | ||
| Q4 25 | — | 0.37× | ||
| Q3 25 | — | 0.39× | ||
| Q2 25 | — | 0.41× | ||
| Q1 25 | — | 0.45× | ||
| Q4 24 | — | 0.47× | ||
| Q3 24 | — | 0.45× | ||
| Q2 24 | — | 0.49× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $18.8M |
| 自由现金流经营现金流 - 资本支出 | — | $18.0M |
| 自由现金流率自由现金流/营收 | — | 27.7% |
| 资本支出强度资本支出/营收 | — | 1.1% |
| 现金转化率经营现金流/净利润 | — | 5.17× |
| 过去12个月自由现金流最近4个季度 | — | $37.9M |
8季度趋势，按日历期对齐
经营现金流GDYNMLAB
| Q1 26 | — | — | ||
| Q4 25 | $9.9M | $18.8M | ||
| Q3 25 | $7.0M | $8.2M | ||
| Q2 25 | $14.4M | $1.9M | ||
| Q1 25 | $9.4M | $12.7M | ||
| Q4 24 | $7.1M | $18.1M | ||
| Q3 24 | $9.2M | $5.3M | ||
| Q2 24 | $10.7M | $10.7M |
自由现金流GDYNMLAB
| Q1 26 | — | — | ||
| Q4 25 | $6.1M | $18.0M | ||
| Q3 25 | $2.9M | $7.1M | ||
| Q2 25 | $10.2M | $884.0K | ||
| Q1 25 | $6.0M | $11.9M | ||
| Q4 24 | $4.4M | $17.3M | ||
| Q3 24 | $5.9M | $3.5M | ||
| Q2 24 | $8.0M | $9.9M |
自由现金流率GDYNMLAB
| Q1 26 | — | — | ||
| Q4 25 | 5.7% | 27.7% | ||
| Q3 25 | 2.8% | 11.7% | ||
| Q2 25 | 10.1% | 1.5% | ||
| Q1 25 | 6.0% | 19.2% | ||
| Q4 24 | 4.4% | 27.6% | ||
| Q3 24 | 6.8% | 6.0% | ||
| Q2 24 | 9.7% | 16.9% |
资本支出强度GDYNMLAB
| Q1 26 | — | — | ||
| Q4 25 | 3.6% | 1.1% | ||
| Q3 25 | 3.9% | 1.8% | ||
| Q2 25 | 4.1% | 1.7% | ||
| Q1 25 | 3.3% | 1.2% | ||
| Q4 24 | 2.6% | 1.3% | ||
| Q3 24 | 3.7% | 3.1% | ||
| Q2 24 | 3.2% | 1.5% |
现金转化率GDYNMLAB
| Q1 26 | — | — | ||
| Q4 25 | 32.34× | 5.17× | ||
| Q3 25 | 5.92× | 3.32× | ||
| Q2 25 | 2.73× | 0.40× | ||
| Q1 25 | 3.21× | — | ||
| Q4 24 | 1.56× | — | ||
| Q3 24 | 2.15× | 1.54× | ||
| Q2 24 | — | 3.17× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
GDYN
暂无分部数据
MLAB
| Sterilization And Disinfection Control | $24.9M | 38% |
| Biopharmaceutical Development | $14.4M | 22% |
| Other | $14.1M | 22% |
| Clinical Genomics | $11.8M | 18% |
